|Articles|November 15, 2019
The Ins and Outs of Incorporating Patient Centricity in Drug Development
Author(s)Parexel
Trending on PharmExec
1
The Current Status of the 340B Program
2
Taking a Hard Look at Pharma's Traditional Margin Model
3
What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates
4
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
5